Literature DB >> 13772195

Comparison of the uricosuric effect of sulfinpyrazone (anturan) and zoxazolamine (flexin).

D B MONTGOMERY, M A OGRYZLO.   

Abstract

Entities:  

Keywords:  PHENYLBUTAZONE/related compounds; URIC ACID/urine; ZOXAZOLAMINE/pharmacology

Mesh:

Substances:

Year:  1960        PMID: 13772195      PMCID: PMC1938791     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Results of a clinical trial of G-28315, a sulfoxide analog of phenylbutazone, as a uricosuric agent in gouty subjects.

Authors:  T F YU; J J BURNS; A B GUTMAN
Journal:  Arthritis Rheum       Date:  1958-12

2.  Value of uricosuric agents and in particular of G. 28 315 in gout.

Authors:  G D KERSLEY; E R COOK; D C TOVEY
Journal:  Ann Rheum Dis       Date:  1958-09       Impact factor: 19.103

3.  Management of gout.

Authors:  W BAUER; M M SINGH
Journal:  N Engl J Med       Date:  1957-01-31       Impact factor: 91.245

4.  Zoxazolamine; a potent uricosuric agent; preliminary report.

Authors:  E B REED; T V FEICHTMEIR; F M WILLETT
Journal:  N Engl J Med       Date:  1958-05-01       Impact factor: 91.245

5.  Evaluation of uricosuric agents in chronic gout.

Authors:  M A OGRYZLO; J HARRISON
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

6.  Clinical experience with a new muscle relaxant, zoxazolamine; preliminary report.

Authors:  W AMOLS
Journal:  J Am Med Assoc       Date:  1956-03-03

7.  Gout--now amenable to control.

Authors:  E C BARTELS
Journal:  Ann Intern Med       Date:  1955-01       Impact factor: 25.391

8.  Sodium salicylate and probenecid in the treatment of chronic gout; assessment of their relative effects in lowering serum uric acid levels.

Authors:  F G MARSON
Journal:  Ann Rheum Dis       Date:  1954-09       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.